Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis
References (0)
Cited by (825)
Gastroesophageal Reflux Disease
2023, Primary Care - Clinics in Office PracticePerception of Proton Pump Inhibitor Side Effects Among Members of the American Broncho-Esophagological Association
2023, Journal of VoiceCitation Excerpt :PPIs decrease gastric acid secretion by irreversibly inhibiting hydrogen-potassium ATPase in parietal cells. They have demonstrated efficacy in the management of GERD and its complications, in risk control of gastrointestinal bleeding and in the prevention of non-steroidal anti-inflammatory drug induced ulcers.2–4 Although initially thought to be free of significant side effects, several observational studies in the past decade have suggested an association between PPI use and concerning adverse events.
Gastroesophageal reflux disease (GERD)
2023, Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions, Second EditionThe efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double-blind, multicenter study
2024, Journal of Gastroenterology and Hepatology (Australia)
Copyright © 1997 Published by Elsevier Inc.